Aliya N. Husain

Aliya N. Husain

Auto-generated profile, based on publicly available information

Aliya N. Husain

Department of Pathology, University of Chicago Medicine, Chicago, United States of America

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
CRCleo E. Rolle
Cleo E. Rolle
RKRajani Kanteti
Rajani Kanteti
MSMosmi Surati
Mosmi Surati
SNSuvobroto Nandi
Suvobroto Nandi
IDIMMANUEL DHANASINGH
IMMANUEL DHANASINGH
Ravi SalgiaRavi Salgia
Ravi Salgia
Small cell lung cancer (SCLC) is a devastating disease, and current therapies have not greatly improved the 5-year survival rates. Topoisomerase (Top) inhibition is a treatment modality for SCLC; however, the response is short lived. Consequently, our research has focused on improving SCLC therapeutics through the identification of novel targets. Previously, we identified MNNG HOS transforming gene (MET) to be overexpressed and functional in SCLC. Herein, we investigated the therapeutic potential of combinatorial targeting of MET using SU11274 and Top1 using 7-ethyl-10-hydroxycamptothecin (SN-38). MET and TOP1 gene copy numbers and protein expression were determined in 29 patients with limited (n = 11) and extensive (n = 18) disease. MET gene copy number was significantly increased (>6 copies) in extensive disease compared with limited disease (P = 0.015). Similar TOP1 gene copy numbers were detected in limited and extensive disease. Immunohistochemical staining revealed a significantly higher Top1 nuclear expression in extensive (0.93) versus limited (0.15) disease (P = 0.04). Interestingly, a significant positive correlation was detected between MET gene copy number and Top1 nuclear expression (r = 0.5). In vitro stimulation of H82 cells revealed hepatocyte growth factor (HGF)–induced nuclear colocalization of p-MET and Top1. Furthermore, activation of the HGF/MET axis enhanced Top1 activity, which was abrogated by SU11274. Combination of SN-38 with SU11274 dramatically decreased SCLC growth as compared with either drug alone. Collectively, these findings suggest that the combinatorial inhibition of MET and Top1 is a potentially efficacious treatment strategy for SCLC. Mol Cancer Ther; 13(3); 576–84. ©2013 AACR.

1 February 1997 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
JMJonathan Muraskas
Jonathan Muraskas
RBRichard Besinger
Richard Besinger
TBTimothy Bell
Timothy Bell
SDSerafin DeLeon
Serafin DeLeon
AHAliya Husain
Aliya Husain
Myocardial infarction in a newborn infant in the absence of congenital heart disease and anomalous coronary artery anatomy is extremely rare. We report a case of a newborn with a structurally normal heart who presented shortly after birth with congestive heart failure and cardiovascular collapse, suggestive of a hypoplastic left ventricle or critical aortic stenosis. This newborn had a massive myocardial infarction caused by thromboembolic occlusion of the left main coronary artery. Clinical, laboratory, and autopsy data suggest the event occurred in utero.

1 October 2023 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
EHEileen Hu-Wang
Eileen Hu-Wang
LCLydia Chelala
Lydia Chelala
LLLuis Landeras
Luis Landeras
HLHuihua Li
Huihua Li
AHAliya N. Husain
Aliya N. Husain
JCJonathan Chung
Jonathan Chung
Pulmonary alveolar proteinosis (PAP) is a rare disease with frequently favorable outcomes. In a minority of patients with primary or secondary PAP, the disease course may be complicated by pulmonary fibrosis (PF) despite appropriate management. Imaging and histopathologic manifestations of uncomplicated PAP are well-known. In contrast, radiologic-pathologic descriptions of PAP-associated PF (PAP-PF) are limited. The current manuscript presents three cases of PAP-PF, each with serial high-resolution CT imaging demonstrating the longitudinal progression of this unusual complication, with concordant pathologic findings in two patients. Much remains to be known regarding adverse prognostic factors contributing to PAP-PF. Early recognition of radiologic-pathologic manifestations would allow timely diagnosis and management optimization.

1 August 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
LCLydia Chelala
Lydia Chelala
AAAyodeji Adegunsoye
Ayodeji Adegunsoye
MSMary Strek
Mary Strek
CLCathryn T. Lee
Cathryn T. Lee
RJRenea Jablonski
Renea Jablonski
JCJonathan Chung
Jonathan Chung
The discordance rate was low between the two current classification systems for diagnosing hypersensitivity pneumonitis on thin-section chest CT scans. Diagnostic performance of each classification... Purpose To compare the diagnostic performance of the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax (ATS/JRS/ALAT) versus the American College of ...

1 January 2008
Verified
Book Chapter
Closed access
PDF file
JSJ. Thomas Stocker
J. Thomas Stocker
AHAliya N. Husain
Aliya N. Husain
LDLouis P. Dehner
Louis P. Dehner

25 March 2026 in Tuberk Toraks
Verified
Journal Article
Closed access
IOİcLal Ocak
İcLal Ocak
FUFurkan Ufuk
Furkan Ufuk
AHAliya Husain
Aliya Husain
Primary salivary gland-type lung cancers are extremely rare, accounting for less than 1% of all lung tumors. Hyalinizing clear cell carcinoma (HCCC) of the lung, an even rarer subtype, presents diagnostic challenges due to its similarity to other endobronchial lesions, such as carcinoid tumors or mucoepidermoid carcinoma. Here, we aimed to present a case of a 53-yearold male non-smoker who presented with recurrent respiratory symptoms. Initial chest X-ray showed consolidation, and subsequent computed tomography (CT) revealed a left lower lobe endobronchial nodule with postobstructive pneumonia. Positron emission tomography-CT imaging demonstrated mild F-18 fluorodeoxyglucose uptake, and bronchoscopy with biopsy led to the diagnosis of HCCC. The patient underwent a left lower lobectomy, and histopathological analysis confirmed the diagnosis. The fiveyear follow-up was unremarkable, with no signs of recurrence. This case underscores the importance of considering HCCC in the differential diagnosis of endobronchial lesions, particularly in non-smokers.